Intended for healthcare professionals


Report lays out strategy to end “postcode prescribing”

BMJ 2000; 320 doi: (Published 15 April 2000) Cite this as: BMJ 2000;320:1027
  1. Jacqui Wise
  1. London

    Expensive drugs should not be available on the NHS until their clinical effectiveness and cost effectiveness have beenevaluated by the National Institute for Clinical Excellence (NICE), a new report concludes.

    A working party report from the Royal College of Physicians, The Prescribing of Costly Medicines, says that once a newmedicine has fulfilled all the criteria for purchase by the NHS then it should become available everywhere. This should …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription